A novel paradigm for dendritic cells as effectors of cartilage destruction

Rheumatology

Volumn 48, Issue 5, 2009, Pages 502-507

  Lakey, Rachel L ^a   Morgan, Tanya G ^a   Rowan, Andrew D ^a   Isaacs, John D ^a   Cawston, Tim E ^a   Hilkens, Catharien M U ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Cartilage destruction; Collagen resorption; Dendritic cells; Tumour necrosis factor

Indexed keywords

CD40 LIGAND; COLLAGEN; HYDROXYPROLINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOASSAY; CARTILAGE DEGENERATION; CELL ACTIVATION; CELL FUNCTION; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EFFECTOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; MONOCYTE; PRIORITY JOURNAL; PROTEIN SECRETION; RHEUMATOID ARTHRITIS; SUPERNATANT; T LYMPHOCYTE;

ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; CARTILAGE, ARTICULAR; CD40 LIGAND; CELLS, CULTURED; COCULTURE TECHNIQUES; COLLAGEN; COLLAGENASES; DENDRITIC CELLS; HUMANS; IMMUNOGLOBULIN GAMMA-CHAINS; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT FUSION PROTEINS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 65249188115     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kep040     Document Type: Article

References (54)

1. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003;423:356-61.
2. Sarkar S, Fox DA. Dendritic cells in rheumatoid arthritis. Front Biosci 2005;10: 656-65.
3. Lutzky V, Hannawi S, Thomas R. Cells of the synovium in rheumatoid arthritis. Dendritic cells. Arthritis Res Ther 2007;9:219.
4. Steinman RM. Dendritic cells: Understanding immunogenicity. Eur J Immunol 2007; 37(Suppl. 1):S53-60.
5. Zvaifler NJ, Steinman RM, Kaplan G, Lau LL, Rivelis M. Identification of immunostimulatory dendritic cells in the synovial effusions of patients with rheumatoid arthritis. J Clin Invest 1985;76:789-800.
6. van Dinther-Janssen AC, Pals ST, Scheper R, Breedveld F, Meijer CJ. Dendritic cells and high endothelial venules in the rheumatoid synovial membrane. J Rheumatol 1990;17:11-7.
7. Thomas R, Davis LS, Lipsky PE. Rheumatoid synovium is enriched in mature antigen-presenting dendritic cells. J Immunol 1994;152:2613-23.
8. Ludewig B, Odermatt B, Landmann S, Hengartner H, Zinkernagel RM. Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue. J Exp Med 1998;188:1493-501.
9. Dittel BN, Visintin I, Merchant RM, Janeway CA Jr. Presentation of the self antigen myelin basic protein by dendritic cells leads to experimental autoimmune encephalomyelitis. J Immunol 1999;163:32-9.
10. Leung BP, Conacher M, Hunter D, McInnes IB, Liew FY, Brewer JM. A novel dendritic cell-induced model of erosive inflammatory arthritis: Distinct roles for dendritic cells in T cell activation and induction of local inflammation. J Immunol 2002;169: 7071-7.
11. Klareskog L, Forsum U, Scheynius A, Kabelitz D, Wigzell H. Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis. Proc Natl Acad Sci USA 1982;79:3632-6.
12. Pettit AR, MacDonald KP, O'Sullivan B, Thomas R. Differentiated dendritic cells expressing nuclear RelB are predominantly located in rheumatoid synovial tissue perivascular mononuclear cell aggregates. Arthritis Rheum 2000;43:791-800.
13. Radstake TR, van der Voort R, ten Brummelhuis M et al. Increased expression of CCL18, CCL19, and CCL17 by dendritic cells from patients with rheumatoid arthritis, and regulation by Fc gamma receptors. Ann Rheum Dis 2005;64:359-67.
14. Bobryshev YV. Dendritic cells in atherosclerosis: Current status of the problem and clinical relevance. Eur Heart J 2005;26:1700-4.
15. Yilmaz A, Lochno M, Traeg F et al. Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques. Atherosclerosis 2004;176:101-10.
16. Page Thomas DP, King B, Stephens T, Dingle JT. In vivo studies of cartilage regeneration after damage induced by catabolin/interleukin-1. Ann Rheum Dis 1991;50:75-80.
17. Jubb RW, Fell HB. The breakdown of collagen by chondrocytes. J Pathol 1980;130: 159-67.
18. Cawston T. Matrix metalloproteinases and TIMPs: Properties and implications for the rheumatic diseases. Mol Med Today 1998;4:130-7.
19. Clark IM, Swingler TE, Sampieri CL, Edwards DR. The regulation of matrix metalloproteinases and their inhibitors. Int J Biochem Cell Biol 2007;40:1362-78.
20. Thomas R, MacDonald KP, Pettit AR, Cavanagh LL, Padmanabha J, Zehntner S. Dendritic cells and the pathogenesis of rheumatoid arthritis. J Leukoc Biol 1999;66: 286-92.
21. Shortman K, Naik SH. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 2007;7:19-30.
22. Morgan AW, Hale G, Rebello PR et al. A pilot study of combination anti-cytokine and anti-lymphocyte biological therapy in rheumatoid arthritis. Q J Med 2008;101: 299-306.
23. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994;179:1109-18.
24. Hilkens CM, Schlaak JF, Kerr IM. Differential responses to IFN-alpha subtypes in human T cells and dendritic cells. J Immunol 2003;171:5255-63.
25. Anderson AE, Sayers BL, Haniffa MA et al. Differential regulation of naive and memory CD4+ T cells by alternatively activated dendritic cells. J Leukoc Biol 2008;84:124-33.
26. Cawston TE, Curry VA, Summers CA et al. The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint. Arthritis Rheum 1998;41:1760-71.
27. Hui W, Rowan AD, Cawston T. Modulation of the expression of matrix metalloproteinase and tissue inhibitors of metalloproteinases by TGF-beta1 and IGF-1 in primary human articular and bovine nasal chondrocytes stimulated with TNF-alpha. Cytokine 2001;16:31-5.
28. Morgan TG, Rowan AD, Dickinson SC et al. Human nasal cartilage responds to oncostatin M in combination with interleukin 1 or tumour necrosis factor alpha by the release of collagen fragments via collagenases. Ann Rheum Dis 2006;65: 184-90.
29. Yeh LA, Augustine AJ, Lee P, Riviere LR, Sheldon A. Interleukin-4, an inhibitor of cartilage breakdown in bovine articular cartilage explants. J Rheumatol 1995;22: 1740-6.
30. Billinghurst RC, Wu W, Ionescu M et al. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase. Arthritis Rheum 2000;43:664-72.
31. Milner JM, Elliott SF, Cawston TE. Activation of procollagenases is a key control point in cartilage collagen degradation: Interaction of serine and metalloproteinase pathways. Arthritis Rheum 2001;44:2084-96.
32. Koshy PJ, Rowan AD, Life PF, Cawston TE. 96-well plate assays for measuring collagenase activity using (3)h-acetylated collagen. Anal Biochem 1999;275:202-7.
33. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 1996; 184:747-52.
34. Holtick U, Marshall SR, Wang XN, Hilkens CM, Dickinson AM. Impact of psoralen/UVA-treatment on survival, activation, and immunostimulatory capacity of monocytederived dendritic cells. Transplantation 2008;85:757-66.
35. Rowan AD, Hui W, Cawston TE, Richards CD. Adenoviral gene transfer of interleukin-1 in combination with oncostatin M induces significant joint damage in a murine model. Am J Pathol 2003;162:1975-84.
36. Hock H, Dorsch M, Kunzendorf U, Qin Z, Diamantstein T, Blankenstein T. Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma. Proc Natl Acad Sci USA 1993; 90:2774-8.
37. Aarvak T, Natvig JB. Cell-cell interactions in synovitis: Antigen presenting cells and T cell interaction in rheumatoid arthritis. Arthritis Res 2001;3:13-7.
38. Rowan AD, Young DA. Collagenase gene regulation by pro-inflammatory cytokines in cartilage. Front Biosci 2007;12:536-50.
39. Zhang Q, Hui W, Litherland GJ et al. Differential toll-like receptor-dependent collagenase expression in chondrocytes. Ann Rheum Dis 2008;67:1633-41.
40. van Kooten C, Banchereau J. CD40-CD40 ligand. J Leukoc Biol 2000;67:2-17.
41. MacDonald KP, Nishioka Y, Lipsky PE, Thomas R. Functional CD40 ligand is expressed by T cells in rheumatoid arthritis. J Clin Invest 1997;100:2404-14.
42. Berner B, Wolf G, Hummel KM, Muller GA, Reuss-Borst MA. Increased expression of CD40 ligand (CD154) on CD4+ T cells as a marker of disease activity in rheumatoid arthritis. Ann Rheum Dis 2000;59:190-5.
43. Kitagawa M, Suzuki H, Adachi Y, Nakamura H, Yoshino S, Sumida T. Interferongamma enhances interleukin 12 production in rheumatoid synovial cells via CD40-CD154 dependent and independent pathways. J Rheumatol 2001;28:1764-71.
44. Harigai M, Hara M, Kawamoto M et al. Amplification of the synovial inflammatory response through activation of mitogen-activated protein kinases and nuclear factor kappab using ligation of CD40 on CD14+ synovial cells from patients with rheumatoid arthritis. Arthritis Rheum 2004;50:2167-77.
45. Popa C, van Lieshout AW, Roelofs MF et al. MIF production by dendritic cells is differentially regulated by toll-like receptors and increased during rheumatoid arthritis. Cytokine 2006;36:51-6.
46. Hui W, Rowan AD, Richards CD, Cawston TE. Oncostatin M in combination with tumor necrosis factor alpha induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo. Arthritis Rheum 2003;48:3404-18.
47. Dubois B, Massacrier C, Vanbervliet B et al. Critical role of IL-12 in dendritic cell-induced differentiation of naive B lymphocytes. J Immunol 1998;161: 2223-31.
48. Rowan AD, Koshy PJ, Shingleton WD et al. Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown. Arthritis Rheum 2001;44:1620-32.
49. Klareskog L, van der Heijde D, de Jager JP et al. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: Double-blind randomised controlled trial. Lancet 2004;363: 675-81.
50. van der Heijde D, Klareskog L, Landewe R et al. Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 2007;56:3928-39.
51. Moghaddami M, Cleland LG, Radisic G, Mayrhofer G. Recruitment of dendritic cells and macrophages during T cell-mediated synovial inflammation. Arthritis Res Ther 2007;9:R120.
52. Santiago-Schwarz F, Anand P, Liu S, Carsons SE. Dendritic cells (DCs) in rheumatoid arthritis (RA): Progenitor cells and soluble factors contained in RA synovial fluid yield a subset of myeloid DCs that preferentially activate TH1 inflammatory-type responses. J Immunol 2001;167:1758-68.
53. Page G, Lebecque S, Miossec P. Anatomic localization of immature and mature dendritic cells in an ectopic lymphoid organ: Correlation with selective chemokine expression in rheumatoid synovium. J Immunol 2002;168:5333-41.
54. Dahlen E, Dawe K, Ohlsson L, Hedlund G. Dendritic cells and macrophages are the first and major producers of TNF-alpha in pancreatic islets in the nonobese diabetic mouse. J Immunol 1998;160:3585-93.